Degludec – First of a New Generation of Insulins
Delivery by Design: Pens for Injectable Therapies
Depression, Antidepressant Medication, and the Risk of Developing Type 2 Diabetes
Detection of Ischemia in Patients with Asymptomatic Diabetes
Developments in Digestive Tract Neuroendocrine Tumors and Pheochromocytomas/Paragangliomas—A Narrative Review
Developments in Digestive Tract Neuroendocrine Tumours and Pheochromocytomas/Paragangliomas – A Narrative Review
Developments in Glycemic Control — Will New Concepts Mean Improved Management of Diabetes?
Developments in Glycemic Control — Will New Concepts Mean Improved Management of Diabetes?
Diabetes and Cardiovascular Risk
Diabetes and Dementia
Diabetes and Depression – A Burdensome Co-morbidity
Diabetes and Oral Health—Current Concepts Regarding Periodontal Disease and Dental Caries
Diabetes and Stem Cells—A 10-year Perspective
Diabetes and Stem Cells—A 10-year Perspective
Diabetes and the Alpha Cell
Diabetes and the Brain—An Overview of Existing Knowledge and Discussions and Future Implications
Diabetes and the Disadvantaged and Vulnerable
Diabetes and the Disadvantaged and Vulnerable
Diabetes and Tuberculosis – Old Associates Posing a Renewed Public Health Challenge
Diabetes and Tuberculosis – Old Associates Posing a Renewed Public Health Challenge
Diabetes as a Paracrinopathy of the Islets of Langerhans
Diabetes Educators in Primary Care—A Natural Fit
Diabetes in Sub-Saharan Africa – Overview of a Looming Health Challenge
Diabetes in Sub-Saharan Africa – Overview of a Looming Health Challenge
Diabetes Risk Scores in 2011
Diabetes Weight Management in Clinical Practice—The Why WAIT Model
Diabetes, Insulin and Pregnancy
Diabetes-associated Erectile Dysfunction
Diabetes-induced Embryopathy—Is Prevention Feasible?
Diabetes—A Pediatric Perspective
Diabetes—A Pediatric Perspective
Diabetic Cardiovascular Autonomic Nerve Dysfunction
Diabetic Cardiovascular Autonomic Neuropathy
Diabetic control and atypical antipsychotics: a case report
Diabetic fetopathy associated with bilateral adrenal hyperplasia and ambiguous genitalia: a case report
Diabetic Foot Complications
Diabetic Foot Complications
Diabetic Gluco-lipotoxic Cardiomyopathy – Amendable by Metabolic Manipulation?
Diabetic Nephropathy and Oxidative Stress
Diabetic Nephropathy and Oxidative Stress
Diagnosis and Management of Acromegaly in 2012
Diagnosis and Management of Acromegaly in 2012
Dilemmas Associated with Hormone Therapy for Post-menopausal Women
Dipeptidyl Peptidase-4 Inhibition
Dipeptidyl Peptidase-4 Inhibition in the Management of Type 2 Diabetes
Dipeptidyl Peptidase-4 Inhibition – Advances in our Understanding of Diabetes Management
Dipeptidyl Peptidase-4 Inhibition – Advances in our Understanding of Diabetes Management
Dipeptidyl Peptidase-4 Inhibitors and the Management of Hyperglycemia
Dipeptidyl Peptidase-4 Inhibitors as Add-on Therapy to Metformin
Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapy
Dispelling the Myths about Rarely Diagnosed Pituitary Disorders
Distal migration of a floating carotid thrombus in a patient using oral contraceptives: a case report
Doing More with What We Already Know—Prevention and Improved Coverage of Healthcare for Diabetes
Doing More with What We Already Know—Prevention and Improved Coverage of Healthcare for Diabetes
DPP-4 Inhibition as a Newly Emerging Therapy for Type 2 Diabetes
Drug Profile – Saxagliptin, a Novel Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes
Drug Profile—Saxagliptin, a Novel Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes